Edwards Lifesciences Corp (EW)
Debt-to-assets ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 597,000 | 596,300 | 595,700 | 595,000 | 594,400 |
Total assets | US$ in thousands | 9,363,200 | 8,292,500 | 8,502,600 | 7,237,100 | 6,488,100 |
Debt-to-assets ratio | 0.06 | 0.07 | 0.07 | 0.08 | 0.09 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $597,000K ÷ $9,363,200K
= 0.06
The debt-to-assets ratio of Edwards Lifesciences Corp has exhibited a declining trend over the five-year period under review. Starting at 0.09 in 2019, the ratio has steadily decreased to 0.06 in 2023. This indicates that the company's proportion of debt relative to its total assets has been decreasing, which can be seen as a positive trend from a solvency and financial risk perspective. Lower debt-to-assets ratios suggest lower financial risk and greater financial stability, as the company relies less on debt financing to support its operations.Overall, the decreasing trend in the debt-to-assets ratio of Edwards Lifesciences Corp reflects a potentially stronger financial position and better debt management by the company over the period analyzed.
Peer comparison
Dec 31, 2023